Q2 25 EPS
$0.03
MISS 79.01%
Est. $0.14
Q2 25 Revenue
$240.3M
BEAT +2.46%
Est. $234.5M
vs S&P Since Q2 25
+445.3%
BEATING MARKET
ICHR +462.0% vs S&P +16.8%
Market Reaction
Did ICHR Beat Earnings? Q2 2025 Results
Ichor Holdings delivered a mixed second quarter for 2025, beating on revenue while falling well short on earnings as one-time restructuring costs weighed heavily on the bottom line. The company posted revenue of $240.28 million, clearing the $234.51 … Read more Ichor Holdings delivered a mixed second quarter for 2025, beating on revenue while falling well short on earnings as one-time restructuring costs weighed heavily on the bottom line. The company posted revenue of $240.28 million, clearing the $234.51 million consensus estimate by 2.46% and marking 18.2% growth year over year, yet non-GAAP diluted EPS of $0.03 missed the $0.14 consensus by 79.01%, sending shares sharply lower. The primary culprit was $4.30 million in operating-level charges tied to the exit of Ichor's Scotland facility, which included inventory write-offs, lease impairments, accelerated depreciation, and severance, compressing GAAP gross margins to 11.3% and widening the net loss to $9.41 million. Free cash flow swung to negative $14.80 million as accounts payable declined and capital spending continued. Looking ahead, management guided Q3 revenue of $225 million to $245 million with non-GAAP EPS of $0.06 to $0.18, projecting improved profitability as Scotland-related costs fade, while CEO Jeff Andreson expressed confidence that Ichor will outperform wafer fab equipment industry growth for the full year.
Key Takeaways
- • Revenue above midpoint of prior guidance range
- • 18.2% year-over-year revenue growth driven by semiconductor capital equipment demand
- • Expansion of proprietary product portfolio
- • Non-GAAP operating margin expanded to 2.6% from 2.2% year-over-year
ICHR YoY Financials
Q2 2025 vs Q2 2024, source: SEC Filings
“Within a relatively steady customer demand environment year-to-date, we continue to make progress driving the expansion of our proprietary product portfolio.”
— Jeff Andreson, Q2 2025 Earnings Press Release
ICHR Earnings Trends
ICHR vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
ICHR EPS Trend
Earnings per share: estimate vs actual
ICHR Revenue Trend
Quarterly revenue: estimate vs actual
ICHR Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $0.13 | $0.15 | +14.16% | $256.1M | +1.89% |
| Q4 25 BEAT FY | $-0.06 | $0.01 | +117.51% | $223.6M | +1.25% |
| FY Full Year | $0.17 | $0.23 | +35.29% | $947.7M | +0.29% |
| Q3 25 MISS | $0.12 | $0.07 | -40.98% | $239.3M | +1.77% |
| Q2 25 MISS | $0.14 | $0.03 | -79.01% | $240.3M | +2.46% |
| Q1 25 MISS | $0.26 | $0.12 | -54.09% | $244.5M | -0.20% |